The role of the β2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 5, 2013, Pages 485-500

  Liu, Xiaoran ^a,b   Tan, Weiping ^a   Liu, Yangli ^a   Lin, Gengpeng ^a   Xie, Canmao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

2 adrenergic receptor; Chronic obstructive pulmonary disease; Endothelial progenitor cells; Repair

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; CHEMOKINE RECEPTOR CXCR4; MONOCLONAL ANTIBODY; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1ALPHA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; WESTERN BLOTTING;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; ANIMALS; ANTIGENS, CD34; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMORAL ARTERY; HUMANS; MICE; MICE, SCID; NOREPINEPHRINE; PROPANOLAMINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA-2; STEM CELLS;

EID: 84876257745     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.773975     Document Type: Review

References (53)

1. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009;4:337-49
2. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997;156(3 Pt 1):814-18
3. Zvezdin B, Milutinov S, Kojicic M, et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest 2009;136(2):376-80
4. Macnee W, Maclay J, McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5(8):824-33
5. Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178(12):1211-18
6. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003;21(5):892-905
7. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31(6):1334-56
8. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-7
9. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95(3):952-8
10. Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002;109(3):337-46
11. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109(5):1801-9
12. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95(4):343-53
13. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005;112(11):1618-27
14. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348(7):593-600
15. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353(10):999-1007
16. Aguila HL. Regulation of hematopoietic niches by sympathetic innervation. Bioessays 2006;28(7):687-91
17. Katayama Y, Battista M, Kao WM, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006;124(2):407-21
18. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Neurosci 1992;15:87-114
19. Steinle JJ, Booz GW, Meininger CJ, et al. Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation. J Biol Chem 2003;278(23):20681-6
20. Spiegel A, Shivtiel S, Kalinkovich A, et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 2007;8(10):1123-31
21. Takahata Y, Takarada T, Iemata M, et al. Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 2009;218(2):268-75
22. Kohm AP, Tang Y, Sanders VM, Jones SB. Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J Immunol 2000;165(2):725-33
23. Fuchs BA, Campbell KS, Munson AE. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol 1988;117(2):339-51
24. Sytkowski AJ, Kessler CJ. The beta-adrenergic receptor adenylate cyclase complex of Rauscher murine erythroleukemia cells and its response to erythropoietin-induced differentiation. Blood 1984;64(1):84-90
25. Fuchs BA, Campbell KS, Munson AE. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol 1988;117(2):339-51
26. Lyte M, Ernst S, Driemeyer J, Baissa B. Strain-specific enhancement of splenic T cell mitogenesis and macrophage phagocytosis following peripheral axotomy. J Neuroimmunol 1991;31(1):1-8
27. Baerwald CG, Wahle M, Ulrichs T, et al. Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis. Immunobiology 1999;200(1):77-91
28. Zhang P, He X, Tan J, et al. Beta-arrestin2 mediates beta-2 adrenergic receptor signaling inducing prostate cancer cell progression. Oncol Rep 2011;26(6):1471-7
29. Liu X, Xie C. Human endothelial progenitor cells isolated from COPD patients are dysfunctional. Mol Cell Biochem 2012;363:53-63
30. Qian L, Hu X, Zhang D, et al. beta2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway. Glia 2009;57(15):1600-9
31. Baloglu E, Reingruber T, Bartsch P, Mairbaurl H. Beta2-adrenergics in hypoxia desensitize receptors but blunt inhibition of reabsorption in rat lungs. Am J Respir Cell Mol Biol 2011;45(5):1059-68
32. Gossl M, Modder UI, Atkinson EJ, et al. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 2008;52(16):1314-25
33. van Beem RT, Noort WA, Voermans C, et al. The presence of activated CD4(+) T cells is essential for the formation of colony-forming unit-endothelial cells by CD14(+) cells. J Immunol 2008;180(7):5141-8
34. Katayama Y, Battista M, Kao WM, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006;124(2):407-21
35. Stellos K, Langer H, Daub K, et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 2008;117(2):206-15
36. Carbajal KS, Schaumburg C, Strieter R, et al. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA 2010;107(24):11068-73
37. Jujo K, Hamada H, Iwakura A, et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA 2010;107(24):11008-13
38. Ryser MF, Ugarte F, Lehmann R, et al. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4- dependent migration and in vivo homing. Mol Immunol 2008;46(1):166-71
39. Gader AM. The effects of beta adrenergic blockade on the responses of leucocyte counts to intravenous epinephrine in man. Scand J Haematol 1974;13(1):11-16
40. Rogausch H, Del RA, Oertel J, Besedovsky HO. Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via beta-adrenergic receptors. Am J Physiol 1999;276(3 Pt 2):R724-30
41. Miles K, Chelmicka-Schorr E, Atweh S, et al. Sympathetic ablation alters lymphocyte membrane properties. J Immunol 1985;135(2 Suppl):797s-801s
42. Madden KS, Moynihan JA, Brenner GJ, et al. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol 1994;49(1-2):77-87
43. Iaccarino G, Ciccarelli M, Sorriento D, et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005;97(11):1182-9
44. Goncharova EA, Goncharov DA, Zhao H, et al. {Beta}2AR agonists modulate human airway smooth muscle cell migration via VASP. Am J Respir Cell Mol Biol 2011
45. LaRocca TJ, Schwarzkopf M, Altman P, et al. Beta2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J Cardiovasc Pharmacol 2010;56(5):548-59
46. Cole SW, Jamieson BD, Zack JA. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J Immunol 1999;162(3):1392-400
47. Schraml E, Quan P, Stelzer I, et al. Norepinephrine treatment and aging lead to systemic and intracellular oxidative stress in rats. Exp Gerontol 2007;42(11):1072-8
48. Bratel T, Wennlund A, Carlstrom K. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD). Effects of long-term oxygen treatment. Respir Med 2000;94(12):1221-8
49. Angeloni E, Melina G, Roscitano A, et al. Beta-blockers improve survival of patients with chronic obstructive pulmonary disease after coronary artery bypass grafting. Ann Thorac Surg 2012
50. Martiniuc C, Branishte T. The use of beta blocker Nebivolol in patients with chronic obstructive pulmonary disease in association with arterial hypertension. Rev Med Chir Soc Med Nat Iasi 2012;116(1):218-21
51. Sandstedt J, Jonsson M, Lindahl A, et al. C-kit+ CD45- cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res Cardiol 2010;105(4):545-56
52. Hibbert B, Ma X, Pourdjabbar A, et al. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc Res 2009;83(1):16-23
53. Sata M, Maejima Y, Adachi F, et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000;32(11):2097-104